The price represents a discount of approximately 7% to Emcure Pharma’s closing price of ₹1,394.10 on the NSE on November 17, 2025. The block deal size is estimated at up to ₹493 crore. Shares of Emcure Pharmaceuticals Ltd ended at ₹1,388, up by ₹15.90, or 1.16%, on the BSE.
